admin

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Ukraine’s parliament is expected to approve a new wartime cabinet, as President Volodymyr Zelenskyy seeks the biggest overhaul of his government since Russia’s full-scale invasion almost 31 months ago.The Verkhovna Rada is…

There’s been a growing interest lately in phased retirement, as indicated by the results of several surveys. For example, more than half (52%) of pre-retirees wish to continue working in some way after they retire, according to The Retirement Outlook of the American Middle Class, a survey whose results were…

Seven GOP-led states have filed a lawsuit challenging the Biden administration’s most recent student debt forgiveness plan, accusing the U.S. Department of Education (DOE) of taking steps to cancel loans beginning as early as this week. The lawsuit comes nearly a week after the Supreme Court denied the Biden administration’s…

Nvidia, the AI chipmaking titan that was briefly the world’s most valuable company, has suddenly found itself in an unfamiliar position: a major rut. Nvidia (NVDA) had the worst day in the history of the stock market Tuesday, as measured by loss in total market value. Its 9.5% share price…

Prime Medicine, Inc. (NASDAQ:PRME) is a gene-editing biotech. Its main platform is Prime Editing, a next-generation technology that can deliver accurate, adaptable, and safer one-time treatments for genetic diseases. This approach can potentially correct specific mutations without the disruptive double-stranded breaks produced by other systems. The company has a diverse…

Stay informed with free updatesSimply sign up to the Equities myFT Digest — delivered directly to your inbox.European and Asian stock markets slid on Wednesday as investors worried about a potential US economic slowdown and sold highly valued technology stocks following a sharp drop in chipmaker Nvidia’s share price.The benchmark…

© 2024 Finances Smart. All Rights Reserved.